Patient P-01485
Synthetic patientNBL-101 · Day 107 · 45–54 · F · baseline S17Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Stable
Discontinuation risk
28%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S17
- Day 40 GI-04 recommended — GI Support Protocol GI-04
- Day 41 Patient accepted — Started GI-04 in the companion
- Day 49 No meaningful change — GI Support Protocol GI-04
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+6
- Treatment adherence-5
- Nutritional resilience-3
What helped?
- GI Support Protocol GI-04Day 40Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion23.8/100
improving · -3.9 vs previous 14 d
Toxicity
Blood29.5/100
stable · -0.6 vs previous 14 d
Sleep quality
Wearable47.5/100
improving · +2.2 vs previous 14 d
Energy level
Daily log5.9/10
stable · +0.2 vs previous 14 d
Stress level
Daily log5.1/10
stable · -0.1 vs previous 14 d
Steps
Wearable7,775
improving · +498 vs previous 14 d
Adherence
Companion90.6 %
stable · +0.5 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 69 from the failing basin, 18 from restoration.
Good elements to keep
- GI Support Protocol GI-04intervention · steering +10.3
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- FUT2 non-secretorhidden · steering -10.6
- Histamine loadperturbation · steering -5.2
- Antibiotic courseperturbation · steering -4.7
- Poor-sleep weekperturbation · steering -3
- Histamine loaddetractor · GI +3.5 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+3.5detractor · 83%
- Alcohol-1.5no signal · 34%
- Simple carbohydrates+0.9no signal · 19%
- Dietary fat load+0.6no signal · 15%
- Insoluble fibre-0.3no signal · 15%
- Spicy / capsaicin-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓60
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- Autonomic recovery ↑25
- WearableResting HR 72 bpm
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 3.6 · butyrate capacity 82/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 40 ms
- Sleep
- 7.0 h
- Steps
- 8,258
- Resting HR
- 71 bpm
Daily log: GI score 24, nutritional resilience 59, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.